Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexey Stepanov

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 31, 2015
Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunityAlexey Belogurov, Ekaterina Kuzina, Anna Kudriaeva, et al.
Materials Science & Engineering. C, Materials for Biological Applications|September 13, 2020
ROS-generation and cellular uptake behavior of amino-silica nanoparticles arisen from their uploading by both iron-oxides and hexamolybdenum clustersSvetlana Fedorenko, Julia Elistratova, Alexey Stepanov, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2022
An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situKai Ye, Fan Li, Ruikun Wang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 4, 2021
Antigen-Specific Stimulation and Expansion of CAR-T Cells Using Membrane Vesicles as Target Cell SurrogatesValeria Ukrainskaya, Yuri Rubtsov, Dmitry Pershin, et al.
Nature Communications|December 11, 2021
Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patientsMichael Maschan, Paolo F Caimi, Jane Reese-Koc, et al.
Nature Communications|May 12, 2021
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomesYu Guo, Lisu Huang, Guangshun Zhang, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 31, 2015
Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunityAlexey Belogurov, Ekaterina Kuzina, Anna Kudriaeva, et al.
Materials Science & Engineering. C, Materials for Biological Applications|September 13, 2020
ROS-generation and cellular uptake behavior of amino-silica nanoparticles arisen from their uploading by both iron-oxides and hexamolybdenum clustersSvetlana Fedorenko, Julia Elistratova, Alexey Stepanov, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2022
An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situKai Ye, Fan Li, Ruikun Wang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 4, 2021
Antigen-Specific Stimulation and Expansion of CAR-T Cells Using Membrane Vesicles as Target Cell SurrogatesValeria Ukrainskaya, Yuri Rubtsov, Dmitry Pershin, et al.
Nature Communications|December 11, 2021
Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patientsMichael Maschan, Paolo F Caimi, Jane Reese-Koc, et al.
Nature Communications|May 12, 2021
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomesYu Guo, Lisu Huang, Guangshun Zhang, et al.
Pageof 3